| Market Cap | ₹7.92Cr |
| ROE | -17.01% |
| P/E Ratio(TTM) | -9.43 |
| EPS(TTM) | -0.21 |
| P/B Ratio | 2.00 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.73 |
| Book Value | 0.99 |
| Debt to Equity | 2.18 |
| Face Value | 1 |
| Parent Organisation | Vivanza Biosciences Limited |
| Managing Director | Mr. Jayendra Mehta |
| BSE Symbol | 530057 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 91.44 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.79 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.00 | ||
| Wockhardt | NA (0.00%) | -142.48 |